baber/WOPTO huggingface dataset:
Patent AU-1611095-A (AU)
Title: Lipopeptide derivatives, a process for their preparation and their use
Inventor: LATTRELL RUDOLF DR
IPC: A61K38/08
Filed: 1995-03-28
Abstract: Lipopeptide derivatives of the formula I    <IMAGE>  I  with R1 equal to OH or NH2 and R2 a C8-C22-acyl radical, pharmaceutical products which are effective for bacterial infections and contain such lipopeptide derivatives, process for preparing the lipopeptide derivatives and the pharmaceutical products, and the use of the lipopeptide derivatives for controlling bacterial infections are described.
Patent AU-1648800-A (AU)
Title: Time-controlled hearing aid
Inventor: BISGAARD NIKOLAI
IPC: H04R25/00
Filed: 1999-12-08
Abstract: A hearing aid which comprises a sound transducer, an analogue-digital converter, a digital processing and adaptation circuit for the processing of digital signals, corresponding to audio signals which are received by the transducer, storage units for the storage of data and programmes for the digital processing and adaptation circuit, a digital-analogue converter and a sound generator. The hearing aid also contains a counter, which registers the time for which the hearing aid has been in use, and a non-volatile storage unit in which the utilisation time is summed up. The hearing aid is arranged in such a manner that a comparison is made between the contents of that part of the non-volatile storage unit in which the summed-up utilisation time is stored and one or more limit values, and so that when one or more of the limit values is reached, a special function is initiated.
Patent AU-1675788-A (AU)
Title: An arrangement for fast frame synchronization
Inventor: SZECHENYI KALMAN
IPC: H04J3/06
Filed: 1988-05-30
Abstract: A fast adjustment of sampling clock phase may be accomplished by calculating the values of the pre-oscillations and post-oscillations that would have been present at each sampling instant to form a correction value so that they may then be subtracted from the measured sample value and only the influence of the distorted unique word remains. Usable control information for readjusting the phase of the sampling clock may thus be derived after only one frame synchronization word has been detected. In a preferred embodiment, the required pre-oscillation and post-oscillation values are derived from the regenerated character data; rather than correcting the sample values themselves, correction values are derived which are used to correct quantities derived from the sample values. The transmission coefficients of the transmission path used to derive the required pre-oscillation and post-oscillation values from the regenerated characters may be either established a priori or derived from the equalization coefficients of an otherwise conventional adaptive equalizer.
Patent AU-1711588-A (AU)
Title: Method for purifying granulocyte-macrophage colony stimulating factor
Inventor: BOONE THOMAS C
IPC: C12N15/00
Filed: 1988-04-19
Abstract: A process for isolating and purifying GM-CSF produced from recombinant sources. The process provides for the isolation and purifying of recombinant GM-CSF produced in E. coli.
Patent AU-1884592-A (AU)
Title: Printed wire boards and method of making same
IPC: H05K1/03
Filed: 1992-05-19
Abstract: PCT No. PCT/EP92/01132 Sec. 371 Date Dec. 2, 1993 Sec. 102(e) Date Dec. 2, 1993 PCT Filed May 19, 1992 PCT Pub. No. WO92/22191 PCT Pub. Date Dec. 10, 1992.A laminate, adapted to be used as a supporting board for a printed circuit, is disclosed which comprises layers of an electrically non-conductive matrix material reinforced with unidirectionally (UD) oriented fibers with the layers comprising individual matrix material having different directions of orientation. The layers are stacked to form a laminate of crossing layers, and the laminate has a core plane relative to which the crossing layers are in mirror image relationship so that the laminate has orthotropic properties. The laminate comprises layers of adhesive material present at least between any pair of layers of UD-reinforced matrix material having different directions of orientation.
Patent AU-1967500-A (AU)
Title: Damage tolerant aluminium alloy product and method of its manufacture
Inventor: HASZLER ALFRED JOHANN PETER
IPC: C22F1/057
Filed: 1999-11-19
Abstract: The invention relates to a Product comprising an aluminium base alloy consisting of (in weight %): Cu3.8-4.9, Mg 1.2-1.8, Mn 0.1-0.9, Fe max. 0.12, Si max. 0.10, Ti max. 0.15, Zn max. 0.20, Cr max. 0.10, impurities each max. 0.05, total max. 0.15, balance aluminium, said product having a minimum L-0.2 % yield strength of 300 MPa or more, a minimum LT-0.2 % yield strength of 270 MPa, a minimum T-L fracture toughness KC(ao) of 100 MPa. 2ROOT m or more for a 700 mm wide CCT-panel, and having in both L/ST- and LT/ST-sections an average grain size of at least 6 according to ASTM E-112. Further the invention relates to a method for the manufacturing of such a product.
Patent AU-2125800-A (AU)
Title: Method and apparatus to counterbalance intrinsic positive end expiratory pressure
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/00
Filed: 2000-01-13
Abstract: An apparatus for providing ventilatory support to a patient, said apparatus comprising an interface (2) to the patient's airway; a supply (1) of breathable gas coupled to said airway interface; a controller (10) configured to control the supply of breathable gas to vary the pressure at the patient interface (2) so as to provide ventilatory support to the patient during inspiration and expiration; and a means of determining respiratory airflow, wherein during expiration the controller (10) is adapted to continually adjust the expiratory pressure to substantially prevent dynamic airway compression and to balance the intrinsic positive end expiratory pressure.
Patent AU-2152897-A (AU)
Title: Alkaline protease deficient filamentous fungi
Inventor: LEHMBECK JAN
IPC: C12N9/60
Filed: 1997-03-26
Abstract: The present invention relates to a filamentous fungus useful for the production of heterologous polypeptides, having been modified by recombinant DNA technology in a manner by which the expression of alkaline proteases have been completely or partially inactivated. The invention also encompasses processes for the production of proteins of interest in high yields by using the fungi of the invention. The invention furthermore relates to methods for producing such fungi and DNA constructs to be used in these methods.
Patent AU-2157500-A (AU)
Title: Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
Inventor: SIKORSKI JAMES A
IPC: A61K31/74
Filed: 1999-12-17
Abstract: The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia and atherosclerosis. Combinations disclosed include a cholesteryl ester transfer protein inhibitor combined with a bile acid sequestrant.
Patent AU-2164795-A (AU)
Title: Electron-beam generating device having plurality of cold cathode elements, method of driving said device and image forming apparatus applying same
Inventor: SUZUKI NORITAKE
IPC: H01J1/304
Filed: 1995-06-13
Abstract: A method and apparatus for driving an electron source in which a high-quality image display is presented by correcting a non-uniform effective current distribution caused in cold cathode elements by leakage current. A digital video signal enters a shift register where a serial-to-parallel conversion is made for each line of an image based upon a shift clock signal. One line of the image data that has been subjected to the serial-to-parallel conversion is latched in a latch circuit and then applied to a voltage modulating circuit. The latter voltage-modulates the input data and sends the modulated signal to a voltage/current converting circuit. The latter converts the voltage quantity to a current quantity, which is applied to each of the cold cathode elements of a display panel through respective column terminals. A voltage V1 is applied to the selected row wire, and a voltage V2 (V2  NOTEQUAL  V1) is applied to all other row wires, for controllig the leakage current. <IMAGE>
Patent AU-2174499-A (AU)
Title: Apparatus for dispensing a predetermined volume of a liquid
Inventor: BACKES MONICA
IPC: B01L3/02
Filed: 1999-01-18
Abstract: Apparatus for dispensing a predetermined volume of a liquid (18) comprises a reservoir (12) for the liquid, a channel (13) provided with an outlet (16) for conveying the liquid (18) from the reservoir to the outlet, and means for generating a pulse of gas. The apparatus is arranged such that the flow of gas causes a predetermined volume of liquid to be ejected from the outlet. The outlet comprises a pair of openings in the channel which face one another, the liquid being retained between the openings by surface tension in the absence of a flow of gas. The gas flow is directed towards one of said openings in use. The apparatus may be used to dispense volumes of a liquid reagent in the range 1 nl to 2 mul. The apparatus avoids contamination of the liquid, and dispensing head construction allows devices to be low cost disposable units. The apparatus is less sensitive to liquid viscosity than existing devices.
Patent AU-2315795-A (AU)
Title: Apparatus for delivery of gas to patients
Inventor: HOWELL PENELOPE JANE
IPC: A61M16/00
Filed: 1995-04-28
Abstract: PCT No. PCT/GB95/00973 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Apr. 28, 1995 PCT Pub. No. WO95/29724 PCT Pub. Date Nov. 9, 1995Apparatus (10) is provided for controlled delivery of gas to a patient. The apparatus is particularly useful for delivery of anaesthetic gases in circumstances where the patient is conscious and able to receive gas upon demand and also where ventilation is poor. The apparatus (10) includes an outlet duct (40) for conveying gas from a gas supply (25) to the patient. A waste gas inlet duct (60) is also provided for receiving gas exhaled by the patient. This is connectable to a suction source (at 35) for scavenging the waste gas. The waste gas inlet duct (60) is arranged so that it can receive gas exhaled by the patient with the outlet duct (via a valve or other diverting means (80)) and around the outlet duct (as guided by shroud (70)).
Patent AU-2373602-A (AU)
Title: Cathodic protective device for flexible pipes
Inventor: BERTON HUGUES
IPC: F16L58/00
Filed: 2001-11-05
Abstract: The flexible pipe comprises a plastic sealing sheath and an inner plastic sheath which define an annular space in which structural elements are placed. The structural elements comprising at least one armor ply consisting of metal wires wound helically with a long pitch are in the space. An end fitting is fitted at each end of the flexible pipe. At least one external anode electronically connected to at least one armor ply. The anode is placed in an intermediate region of the flexible pipe distal from the end fittings. A connection means connects the anode to at least one of the metal wires of the said armor ply in the intermediate region.
Patent AU-2570195-A (AU)
Title: Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
Inventor: FAURRE FLORENCE
IPC: C12P21/08
Filed: 1995-05-05
Abstract: Soluble polypeptide fraction consisting of all or part of one at least one of the four immunoglobulin-type extracellular LAG-3 protein domains (amino acids 1-159, 160-230, 240-330 and 331-412 of the SEQ ID NO:1 sequence) or consisting of one peptide sequence derived from these domains by replacement, addition or deletion of one or more amino acids. The fraction of the invention has a specificity at least equal to that of LAG-3 in relation to its ligand.
Patent AU-2714199-A (AU)
Title: A signal processing method to analyse transients of speech signals
Inventor: LEONHARD FRANK ULDALL
IPC: A61B5/0476
Filed: 1999-03-12
Abstract: An input signal (i(t)) having an input frequency-bandwidth is decomposed into a first plurality of signals each representing a distinct, frequency-bandwidth limited portion of the input signal, and for each of the first plurality of signals a signal representing an envelope thereof is provided. The method further comprises, for each signal representing an envelope, providing a second plurality of signals (Oij(t)) each representing a distinct frequency bandwidth-limited portion of the signal representing an envelope. The envelope is preferably provided through rectification and low-pass filtering. The method is useful for analysing a human speech signal for identifying vowels in the speech signal, and for analysing a signal generated by an industrial product. <IMAGE>
Patent AU-2734397-A (AU)
Title: Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
Inventor: SCHLOM JEFFREY
IPC: C12N15/12
Filed: 1997-04-17
Abstract: Mutant ras oncogene peptides may induce specific anti-ras cellular immune responses in vaccinated patients. Moreover, a human CD8+ CTL epitope(s) reflecting a specific point mutation in the K-ras oncogene at codon 12 was identified. The mutant ras peptide has implications for both active and passive immunotherapies in selected carcinoma patients. A nested 10-mer peptide was identified [i.e., ras5-14(Asp12)], which was shown to bind to HLA-A2 and display specific functional capacity for expansion of the in vivo-primed CD8+ CTL precursors.
Patent AU-2917600-A (AU)
Title: Emulsion crystallisation with recycle
Inventor: REUTER KARL
IPC: B01D9/02
Filed: 2000-03-08
Abstract: A method for purifying substances through emulsion crystallisation is described, whereby (a) an emulsion of organic liquid droplets in a continuous water phase containing the impure substance is formed; (b) the emulsion is super-saturated in the substance; (c) crystallisation of the substance in the water phase is induced; (d) the crystals of the substance are isolated from the from emulsion, yielding an emulsion-filtrate; (e) additional impure substance is dissolved in the emulsion-filtrate; and (f) steps (b)-(d) are repeated with the emulsion obtained from step (e).
Patent AU-2978684-A (AU)
Title: Prostacyclin derivatives
Inventor: SKUBALLA WERNER
IPC: C07C47/14
Filed: 1984-06-22
Abstract: 1. 5-Cyanoprostacyclines of the general formula I   see diagramm : EP0130142,P10,F2   wherein A represents a _t_r_a_n_s-CH = CH- or -C -= C- group, W represents a hydroxymethylene, acetoxymethylene,   see diagramm : EP0130142,P10,F3   wherein the OH or acetoxy group may have the alpha- or b¢eta-configuration, D and E together represent a direct bond or D represents a straight-chained alkylene group having from 1 to 5 C atoms or a branched alkylene group having from 2 to 5 C atoms, E represents an oxygen atom, a -C -= C- bond or a direct bond, R2 represents a C1 -C7 -alkyl group or phenyl, R1 represents a hydroxy or acetoxy group and R3 represents the acetal radicals   see diagramm : EP0130142,P11,F1
Patent AU-3130393-A (AU)
Title: Method and apparatus for treating tissue damage
IPC: A61B19/00
Filed: 1992-11-12
Abstract: The invention disclosed is a method of treating tissue damage comprising applying a negative pressure to a wound sufficient in time and magnitude to promote tissue migration and thus facilitate closure of the wound. The method is applicable to wounds, burns, infected wounds, and live tissue attachments. Configurations of apparatus for carrying out the method are also disclosed.
Patent AU-3142195-A (AU)
Title: Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
Inventor: HALL BONNIE JOY
IPC: A61K31/16
Filed: 1995-07-21
Abstract: The present invention relates to compositions for treating acne and other skin lesions and also to methods of treatment utilizing these compositions. These compositions and methods of treatment employ benzoyl peroxide, a compound for reducing the skin irritation associated therewith, and a topical carrier.
Patent AU-3247899-A (AU)
Title: New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
Inventor: JESSEN CLAUS ULRIK
IPC: C07K5/065
Filed: 1999-02-26
Abstract: This invention relates to salt forms of (2E)-5- amino-5methylhex-2- enoic acid N-methyl-N-((1R)-1- (N-methyl-N-((1R)-1- (methylcarbamoyl)-2-phenylethyl)carbamoyl)-2- (2-naphthyl)ethyl)amide, preparation thereof and use as therapeutic agent.
Patent AU-3270193-A (AU)
Title: Separating arrangement and method for counteracting foam formation
Inventor: BROTTGARDH GORAN
IPC: B04C5/13
Filed: 1992-12-03
Abstract: PCT No. PCT/SE92/00835 Sec. 371 Date Jun. 23, 1994 Sec. 102(e) Date Jun. 23, 1994 PCT Filed Dec. 3, 1992 PCT Pub. No. WO93/12889 PCT Pub. Date Jul. 8, 1993The present invention relates to a cyclone, mainly for separating liquid from gas/vapor which is formed on pressure reduction of spent cooling liquor in connection with pulp production. The cyclone includes a casing, an inlet arrangement, a lower outlet line for liquid and an upper outlet line for vapor and gas. The inlet arrangement is connected to a supply line with a valve and the inlet arrangement consists of an exchangeable insertion pipe, the length of which exceeds one meter, preferably two meters and is most preferably between 2.5 and 3.5 meters long.
Patent AU-3278800-A (AU)
Title: Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
Inventor: ASMUSSEN BODO
IPC: A61K31/519
Filed: 2000-02-08
Abstract: Desoxypeganine and its pharmaceutically acceptable acid addition salts can be used in the treatment of drug addiction or drug dependence. Said substances are administered preferably in a continuos and controlled manner. The pharmaceutical administration form enables controlled release, e.g. for oral transdermal or another route of parenteral administration.
Patent AU-3434699-A (AU)
Title: Appendage correction device
Inventor: FOOTE BRIAN
IPC: A61F5/01
Filed: 1999-04-12
Abstract: There is disclosed a medical correction device for correcting the attitude of an appendage of the user which is prone to adopting an undesirable attitude, as is the case for example in conditions such as clawed fingers or dropped foot. The device comprises a base portion with means for securing the device to a user to which a resilient member such as a coiled spring, and a rotatable projection member are attached. The resilient member is also attached to the rotatable projection member and subtends an angle therewith. The device is mounted on a hand, wrist or proximate the ankle of the user such that relative rotation between the projection member and the base portion gives rise to a restoring force exerted by the resilient member, a component of which acts on the appendage. The interaction between the appendage of the user, projection member and the base portion is such that increased rotation of the projection member away from the base portion reduces the angle subtended between the projection member and the resilient member and accordingly the component of the restoring force transmitted by said projection member back to the base portion is increased and the component of the restoring force which acts on the appendage is reduced and substantially eliminated when the projection member and the resilient member are in alignment. The correcting effects of the device is therefore reduced and can be eliminated when the appendage is significantly angled with respect to the portion of the user to which said appendage is attached.
Patent AU-3435900-A (AU)
Title: Method and device in winding of a web
Inventor: LESKINEN ARTO
IPC: B65H18/14
Filed: 2000-03-16
Abstract: A web roll is wound (11) by passing the web onto a core (12) via a pressure nip (N) formed between a winding drum (10) and the roll (11), whereby the core (12) is supported by chucks (14) mounted on roll support arms (13). The pressing-nip force in the nip (N) formed between the roll (11) and the winding drum (10) is controlled using a position-feedback technique in which the movements of the roll support arms (13) are synchronized. Moreover, the support arms are moved is response to a control unit which uses a physical model of the winding process which predicts roll diameter at any time. When force sensors which detect an increase in pressure the arms can be advanced to promote even winding of the roll.
Patent AU-3529199-A (AU)
Title: Use of a polypeptide derived from a pa1b legume albumen as insecticide
Inventor: DELOBEL BERNARD
IPC: C07K14/415
Filed: 1999-05-07
Abstract: The invention concerns the use of a polypeptide derived from a PAlb legume albumen as insecticide, particularly for protecting cereal grains against insect pests.
Patent AU-3637095-A (AU)
Title: Method and apparatus for storing data using spin-polarized electrons
Inventor: HURT THOMAS D
IPC: G11B5/012
Filed: 1995-09-21
Abstract: An electron emission device for generating and emitting spin-polarized electrons comprising: a first conducting material; a magnetic ultrathin film magnetically coupled to the first conducting material; an electrically insulative and magnetically permeable medium being located between the first conducting material and the magnetic ultrathin film; a second conducting material formed into a structure that emits electrons when impinged by an electric field and electrically coupled to the magnetic ultrathin film; and an anode, electrically coupled to the structure that emits electrons, for generating the electric field that impinges on the structure that emits electrons. <IMAGE>
Patent AU-3841502-A (AU)
Title: Isoindolin-1-one glucokinase activators
Inventor: GUERTIN KEVIN RICHARD
IPC: C07D277/42
Filed: 2001-12-07
Abstract: Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
Patent AU-3893095-A (AU)
Title: Use of 2'-substituted oligonucleotides to down-regulating gene expression
Inventor: AGRAWAL SUDHIR
IPC: A61K/
Filed: 1995-10-17
Abstract: Disclosed is a method of down-regulating the expression of a gene in an animal, wherein a pharmalogical formulation comprising an oligonucleotide complementary to the gene is orally administered to an animal. The oligonucleotide administered has non-phosphodiester internucleotide linkages and includes at least one 2'-substituted ribonucleotide, the oligonucleotide inhibiting the expression of a product of the gene, thereby down-regulating the expression of the gene.
Patent AU-3924089-A (AU)
Title: Cell culture apparatus
Inventor: AMIOT BRUCE P
IPC: C12M3/00
Filed: 1989-08-02
Abstract: A compact, easily assembled cell culturing device comprising at least one envelope (12), the interior of which defines a cell culturing space wherein the envelope is spirally wrapped about an elongated core and which provides for optimal gas delivery and removal to and from the cell culturing space which is also separate from nutrient media delivery and removal whereby greater amounts of oxygen are provided to the cells at a faster rate to produce cells and/or cell products more economically and in higher yield.
Patent AU-3950699-A (AU)
Title: Serrated adhesive tape
Inventor: BRANDWIJK PIET
IPC: C09J7/22
Filed: 1999-06-07
Abstract: An adhesive tape (1) especially for forming a package or a bundle of objects is presented which has serrated borders (2) and at least one perforation line (3) extending in lengthwise direction of the adhesive tape. In addition a method for applying the adhesive tape (1) to form a package or a bundle of objects is described. At least two rows of parallelepipedon shaped objects (4) are placed next to each other and at endfaces (6) thereof a strip of adhesive tape (1) will be provided such that the perforation line of the adhesive tape will be situated approximately at the dividing line between the two endfaces of the adjacent objects.